BR9712072A - Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma - Google Patents

Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma

Info

Publication number
BR9712072A
BR9712072A BR9712072A BR9712072A BR9712072A BR 9712072 A BR9712072 A BR 9712072A BR 9712072 A BR9712072 A BR 9712072A BR 9712072 A BR9712072 A BR 9712072A BR 9712072 A BR9712072 A BR 9712072A
Authority
BR
Brazil
Prior art keywords
defditoren
pivoxil
production
crystalline substance
crystalline
Prior art date
Application number
BR9712072A
Other languages
English (en)
Inventor
Kiyoshi Ysui
Masahiro Onodera
Masamichi Sukegawa
Tatsuo Watanabe
Yuichi Yamamoto
Yasushi Murai
Katsuharu Linuma
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of BR9712072A publication Critical patent/BR9712072A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
BR9712072A 1996-09-20 1997-09-19 Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma BR9712072A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24956196 1996-09-20
PCT/JP1997/003340 WO1998012200A1 (en) 1996-09-20 1997-09-19 A crystalline substance of cefditoren pivoxyl and the production of the same

Publications (1)

Publication Number Publication Date
BR9712072A true BR9712072A (pt) 1999-08-24

Family

ID=17194838

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712072A BR9712072A (pt) 1996-09-20 1997-09-19 Subst-ncia cristalina de defditoren pivoxil e a produ-Æo da mesma

Country Status (25)

Country Link
US (2) US6294669B1 (pt)
EP (1) EP0937083B1 (pt)
JP (1) JP3403206B2 (pt)
KR (1) KR100441907B1 (pt)
CN (1) CN1116299C (pt)
AR (1) AR008483A1 (pt)
AT (1) ATE238310T1 (pt)
AU (1) AU714735B2 (pt)
BR (1) BR9712072A (pt)
CA (1) CA2265686C (pt)
CZ (1) CZ295199B6 (pt)
DE (1) DE69721290T2 (pt)
EA (1) EA001526B1 (pt)
ES (1) ES2198593T3 (pt)
HU (1) HU224196B1 (pt)
ID (1) ID22064A (pt)
IL (1) IL129016A (pt)
NZ (1) NZ334883A (pt)
PL (1) PL189548B1 (pt)
PT (1) PT937083E (pt)
RO (1) RO120196B1 (pt)
SK (1) SK284973B6 (pt)
TR (1) TR199900614T2 (pt)
UA (1) UA55426C2 (pt)
WO (1) WO1998012200A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU224196B1 (hu) * 1996-09-20 2005-06-28 Meiji Seika Kaisha Ltd. Cefditoren-pivoxil kristályos formája, és eljárás annak előállítására
PT1051978E (pt) 1998-01-07 2012-11-20 Meiji Seika Pharma Co Ltd Composições de cefalosporina amorfa cristalograficamente estável e processo para a sua produção
AR025976A1 (es) 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
HU226640B1 (en) * 1999-10-18 2009-05-28 Egis Gyogyszergyar Nyilvanosan Process for producing amorphous atorvastatin calcium salt
JP2001131071A (ja) * 1999-10-29 2001-05-15 Meiji Seika Kaisha Ltd 非晶質および非晶質を含有する医薬組成物
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
ES2361739T3 (es) * 2002-08-16 2011-06-21 Immunogen, Inc. Reticulantes con elevada reactividad y solubilidad y su uso en la preparación de conjugados para el suministro dirigido de fármacos de molécula pequeña.
EP1555024B1 (en) * 2002-10-02 2010-09-29 Meiji Seika Kaisha Ltd. Antibacterial medicinal composition of enhanced oral absorptivity
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
CA2508792C (en) 2002-12-06 2013-02-05 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
WO2004082586A2 (en) * 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
JP5230934B2 (ja) * 2003-03-27 2013-07-10 バジリア ファルマスーチカ アーゲー 結晶形態のセファロスポリン
US8088387B2 (en) * 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
WO2005016936A2 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Process for selective preparation of z-isomer of cefditoren and pharmaceutically acceptable salts and esters thereof
PT1671635E (pt) 2003-10-08 2012-01-17 Meiji Seika Pharma Co Ltd Composição de antibiótico amorfo contendo cefditoreno pivoxil
JP2007510709A (ja) * 2003-11-07 2007-04-26 ランバクシー ラボラトリーズ リミテッド 高純度3−(2−置換ビニル)セファロスポリンの製法
JP2005162696A (ja) * 2003-12-04 2005-06-23 Nichiko Pharmaceutical Co Ltd 溶出性に優れたセフジトレンピボキシル製剤
CA2568914C (en) * 2004-06-04 2013-09-24 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
WO2006024900A1 (en) * 2004-08-31 2006-03-09 Ranbaxy Laboratories Limited Highly pure cefditoren pivoxil
EP1973902A2 (en) * 2005-12-05 2008-10-01 Affinium Pharmaceuticals, Inc. 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
US20080069879A1 (en) * 2006-05-02 2008-03-20 Ravishekhar Bhiwgade Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
EP2520578A1 (en) 2011-05-06 2012-11-07 Lupin Limited Process for purification of cephalosporins
CN103421025B (zh) * 2012-05-21 2016-05-11 上海医药工业研究院 制备7α-甲氧基头孢菌素C的方法
SMT201900411T1 (it) 2012-06-19 2019-09-09 Debiopharm Int Sa Derivati di profaramci di (e)-n-metil-n-((3-metilbenzofuran-2-il)metil -3-(7-osso-5,6,7,8-tetraidro-1,8-naftiridin-3-il)acrilammide
KR101561963B1 (ko) * 2013-05-23 2015-10-22 영진약품공업 주식회사 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
CN103665002B (zh) * 2013-12-18 2016-02-03 成都医路康医学技术服务有限公司 一种头孢妥仑匹酯的制备方法
WO2016114727A1 (en) 2015-01-16 2016-07-21 Öğün Yusuf Toktamiş Cefditoren pivoxil compositions with improved stability and production methods thereof
BR122023021456A2 (pt) 2016-02-26 2024-02-20 Debiopharm International S.A. Uso de di-hidrogeno fosfato de {6- [(e)-3-{metil[(3-metil-1-benfofuran-2- iol)metil]amino)-3- oxopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)- il}metila para tratamento de osteomielite do pé diabético e composição farmacêutica
FI3923914T3 (fi) 2019-02-14 2023-04-27 Debiopharm Int Sa Afabisiiniformulaatio, menetelmä sen valmistamiseksi
MA56184A (fr) 2019-06-14 2022-04-20 Debiopharm Int Sa Afabicine pour utilisation dans le traitement d'infections bactériennes impliquant un biofilm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
US5827845A (en) * 1993-09-29 1998-10-27 Meiji Seika Kaisha, Ltd. Cephalosporin derivative
EP0658558B1 (en) * 1993-11-17 2001-01-24 Biochemie Gesellschaft M.B.H. Separation of cephalosporin isomers
HU224196B1 (hu) * 1996-09-20 2005-06-28 Meiji Seika Kaisha Ltd. Cefditoren-pivoxil kristályos formája, és eljárás annak előállítására

Also Published As

Publication number Publication date
EA001526B1 (ru) 2001-04-23
JP2001500521A (ja) 2001-01-16
HU224196B1 (hu) 2005-06-28
TR199900614T2 (xx) 1999-06-21
EP0937083B1 (en) 2003-04-23
US20020002279A1 (en) 2002-01-03
ID22064A (id) 1999-08-26
HUP9903454A3 (en) 2001-04-28
PT937083E (pt) 2003-08-29
CN1116299C (zh) 2003-07-30
CA2265686C (en) 2006-10-31
AU4222297A (en) 1998-04-14
DE69721290D1 (de) 2003-05-28
PL189548B1 (pl) 2005-08-31
AU714735B2 (en) 2000-01-13
NZ334883A (en) 2000-09-29
KR100441907B1 (ko) 2004-07-27
EP0937083A1 (en) 1999-08-25
US6294669B1 (en) 2001-09-25
SK284973B6 (sk) 2006-03-02
SK35499A3 (en) 2000-03-13
KR20000048496A (ko) 2000-07-25
IL129016A (en) 2003-01-12
WO1998012200A1 (en) 1998-03-26
CA2265686A1 (en) 1998-03-26
ATE238310T1 (de) 2003-05-15
CZ97599A3 (cs) 1999-08-11
DE69721290T2 (de) 2004-01-22
PL332314A1 (en) 1999-08-30
AR008483A1 (es) 2000-01-19
CZ295199B6 (cs) 2005-06-15
US6441162B2 (en) 2002-08-27
HK1022912A1 (en) 2000-08-25
IL129016A0 (en) 2000-02-17
EA199900311A1 (ru) 1999-10-28
HUP9903454A2 (hu) 2000-03-28
UA55426C2 (uk) 2003-04-15
CN1234036A (zh) 1999-11-03
ES2198593T3 (es) 2004-02-01
RO120196B1 (ro) 2005-10-28
JP3403206B2 (ja) 2003-05-06

Similar Documents

Publication Publication Date Title
IL134871A0 (en) Polymeric derivatives of campothecins
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
DE69417098D1 (de) Biologisch abbaubarer medullärer Pfropfen
IL129016A0 (en) A crystalline substance of cefditoren pivoxyl and the production of the same
BR9612126A (pt) Derivados de benzazepina
DE59507573D1 (de) Implantat
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
FI972090A0 (fi) Antibakteeriset dibentsimidatsolijohdannaiset
FI955783L (fi) Pyrrolijohdannaisia
PL331470A1 (en) Azabicyclocarbamoyloxylic derivatives of mutiline for antibacterial applications
BR9509793A (pt) Derivados de tiofeneno
PT829205E (pt) Producao de condimento
FI962602L (fi) Antimikrobiellejä ja anti-inflammatoorisia yhdisteitä
FI973500A7 (fi) 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset
NO992526D0 (no) Cephalosporin-derivater
FI933019A7 (fi) Bentsotiatsepiini- ja bentsoksatsepiinijohdannaisia
IL130209A (en) Therapeutic application of a thienylcylohexylamine derivatives
BR9506618A (pt) Derivados de difeniloxazolinas
FR2735016B1 (fr) Implant endo-luminal
PL334276A1 (en) Micromolecular form of derivatives of tetrahydropyridine
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
NO964162L (no) Tidsur
BR9506613A (pt) Derivados de feniltio-oxazolinas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO ENCONTRA-SE EM DESACORDO COM OS ARTS. 8O, 11E 13 DA LPI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]